¼¼°èÀÇ MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀå
MIS Sacroiliac Joint Fusion
»óǰÄÚµå : 1643330
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 467 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

MIS õÀå°üÀý °íÁ¤¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 17¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â 8¾ï 6,810¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â MIS õÀå°üÀý °íÁ¤¼ú ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 11.5% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, MIS õÀå°üÀý °íÁ¤¼ú º¸°í¼­¿¡¼­ ºÐ¼®µÈ ºÎ¹® Áß ÇϳªÀÎ ÀÓÇöõÆ® ºÎ¹®Àº ¿¬Æò±Õ 12.5%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àº CAGR 12.5%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ ¸»±îÁö 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, MIS õÀå°üÀý °íÁ¤¼ú ±â±â ¹× Àåºñ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 3,650¸¸ ´Þ·¯, Áß±¹Àº CAGR 15.8%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº 2024³â 2¾ï 3,650¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 15.8%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â±îÁö 3¾ï 5,070¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 8.3%¿Í 10.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 9.1%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

MIS õÀå°üÀý °íÁ¤¼úÀÌ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Àα⸦ ²ô´Â ÀÌÀ¯´Â?

ÃÖ¼Òħ½ÀÀû õÀå°üÀý(SI) °íÁ¤¼úÀº õÀå°üÀý ±â´É Àå¾Ö·Î ÀÎÇÑ ¸¸¼º ¿äÅëÀ¸·Î °íÅë¹Þ´Â ȯÀÚµéÀ» À§ÇÑ È¹±âÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. ÅðÇ༺ õÀå°üÀý¿°, ¿Ü»ó, °üÀý¿° µîÀÇ Ä¡·á°¡ ´ëÁßÈ­µÇ¸é¼­ È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ¼ö¼úÀû Á¢±Ù¹ý°ú´Â ´Þ¸®, ÃÖ¼Òħ½ÀÀû ±â¼úÀº ȸº¹ ½Ã°£ ´ÜÃà, Àý°³ ºÎÀ§ Ãà¼Ò, ¼ö¼ú ÈÄ ºÒÆí°¨ °¨¼Ò·Î ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡ ÀÇÇØ Á¡Á¡ ´õ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, SI °üÀýÀÇ ±â´É Àå¾Ö¿¡ Ãë¾àÇÑ °í·ÉÈ­ Àα¸ÀÇ Áõ°¡µµ MIS ½Ã¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, õÀå°üÀý ¹®Á¦ÀÇ Á¶±â Áø´Ü ¹× Ä¡·áÀÇ ´Ù¸¥ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í±Þ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ¿© ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº MIS õÀå°üÀý °íÁ¤¼ú¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿À°í Àִ°¡?

ÀÇ·á ±â¼úÀÇ ¹ßÀüÀº MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀÇ ±Þ°ÝÇÑ ¼ºÀåÀÇ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. ¿µ»ó Áø´Ü ¹× ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀÇ Çõ½ÅÀº ¼ö¼ú Á¤È®µµ¸¦ Å©°Ô Çâ»ó½Ã۰í ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̸ç ȯÀÚ °á°ú¸¦ °³¼±Çß½À´Ï´Ù. ƼŸ´½ ¹× »ýü Ȱ¼º ¹°Áú°ú °°Àº »õ·Î¿î ÀÓÇöõÆ® Àç·áÀÇ °³¹ßÀº ÀÓÇöõÆ®ÀÇ ³»±¸¼º°ú ÅëÇÕ¼ºÀ» Çâ»ó½ÃÄÑ ´õ ³ªÀº ȸº¹°ú Àå±âÀûÀÎ °á°ú¸¦ °¡Á® ¿Ô½À´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼ú°ú ÄÄÇ»ÅÍ º¸Á¶ °èȹ µµ±¸´Â ¼ö¼úÀ» ´õ¿í °£¼ÒÈ­ÇÏ¿© ¿Ü°ú Àǻ簡 ÃÖ¼Òħ½ÀÀ¸·Î ´õ ³ôÀº Á¤È®µµ¸¦ ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú °èȹ¿¡ Áõ°­Çö½Ç(AR)À» ÅëÇÕÇÔÀ¸·Î½á ¿Ü°úÀǻ簡 º¹ÀâÇÑ »ç·Ê¸¦ ½Ã°¢È­Çϰí Á¢±ÙÇÏ´Â ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ÀÓ»ó È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó MIS ¼ö¼úÀ» ¼±ÅÃÇϴ ȯÀÚµéÀÇ ½Å·Úµµ¸¦ ³ô¿© ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±Ëµµ¸¦ Çü¼ºÇÏ´Â Áö¿ª ¿ªÇÐÀº ¹«¾ùÀΰ¡?

MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº ´Ù¾çÇÑ ÀÇ·á ÀÎÇÁ¶ó, °æÁ¦ »óȲ, ȯÀÚ Àα¸Åë°è¿¡ µû¶ó Áö¿ªº°·Î ºÒ±ÕµîÇÏ°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ³ôÀº ÀÇ·áºñ ÁöÃâ, È®¸³µÈ »óȯ ÇÁ·¹ÀÓ¿öÅ©, ÷´Ü ÀÇ·á±â¼úÀÇ °¡¿ë¼ºÀ¸·Î ÀÎÇØ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº õÀå°üÀý ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿¡ ÈûÀÔ¾î ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾî ÅõÀÚ Áõ°¡, SI °üÀý ±â´É Àå¾Ö¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ±Þ¼ÓÇÑ °í·ÉÈ­·Î ÀÎÇØ ÀáÀç·ÂÀÌ Å« ½ÃÀåÀ¸·Î ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Àεµ, Áß±¹ µî ½ÅÈï±¹ Á¤ºÎ´Â ÀÇ·á Á¢±Ù¼º È®´ë¿¡ Èû¾²°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ħÅõ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÀÇ·á°ü±¤ÀÇ Áõ°¡·Î MIS ±â¼úÀÌ Á¡Â÷ÀûÀ¸·Î äÅõǰí ÀÖ½À´Ï´Ù.

MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

MIS õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀÇ ¼ºÀåÀº ¼ö¼ú ±â¼úÀÇ ¹ßÀü°ú ȯÀÚÀÇ ¼±È£µµ º¯È­ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ³ë³âÃþ°ú ¿îµ¿·®ÀÌ ¸¹Àº »ç¶÷µé »çÀÌ¿¡¼­ ¿äÅë ¹× °ü·Ã ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀ̰í ÃÖ¼Òħ½ÀÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¿Í R&D ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡´Â º¸´Ù È¿À²ÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ ¼ö¼ú µµ±¸¿Í ÀÓÇöõÆ® °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¶±â °³ÀÔÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡µéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ½Ã¼úÀÇ Ã¤Å÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼±Áø±¹ÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥ ¹× ½ÅÈï ½ÃÀå¿¡¼­ÀÇ Àü¹® ¼ö¼úÀÇ °¡¿ë¼º È®´ë´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© MIS õÀå°üÀý °íÁ¤¼úÀº Áõ°¡ÇÏ´Â ÀÇ·á ¼ö¿ä¿¡ È¿À²ÀûÀ̰í È¿°úÀûÀ¸·Î ´ëÀÀÇÒ ¼ö ÀÖ´Â Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(MIS õÀå°üÀý °íÁ¤¼ú ÀÓÇöõÆ®, MIS õÀå°üÀý °íÁ¤¼ú ±â±¸ ¹× Àåºñ), Á¢±Ù¹ý(ÈĹæ Á¢±Ù¹ý, Àü¹æ Á¢±Ù¹ý), ÀûÀÀÁõ(ÅðÇ༺ õÀå°üÀý¿° ÀûÀÀÁõ, ¿Ü»ó ÀûÀÀÁõ, õÀå°üÀý ±â´ÉºÎÀü ÀûÀÀÁõ), ÃÖÁ¾ ¿ëµµ(º´¿ø¿ë, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÁÖ¸ñ¹Þ´Â 44°³ ±â¾÷)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global MIS Sacroiliac Joint Fusion Market to Reach US$1.7 Billion by 2030

The global market for MIS Sacroiliac Joint Fusion estimated at US$868.1 Million in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. MIS Sacroiliac Joint Fusion Implants, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the MIS Sacroiliac Joint Fusion Instruments & Equipment segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$236.5 Million While China is Forecast to Grow at 15.8% CAGR

The MIS Sacroiliac Joint Fusion market in the U.S. is estimated at US$236.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$350.7 Million by the year 2030 trailing a CAGR of 15.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Global MIS Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is MIS Sacroiliac Joint Fusion Gaining Popularity in the Healthcare Sector?

Minimally invasive sacroiliac (SI) joint fusion has emerged as a transformative solution for patients suffering from chronic lower back pain caused by sacroiliac joint dysfunction. The growing prevalence of conditions such as degenerative sacroiliitis, trauma, and arthritis has amplified the demand for effective treatment options. Unlike traditional surgical approaches, minimally invasive techniques offer reduced recovery times, smaller incisions, and less post-operative discomfort, making them increasingly preferred by both patients and healthcare providers. The global rise in aging populations, who are more susceptible to SI joint dysfunction, is also a significant factor driving the adoption of MIS techniques. Additionally, the increasing awareness of the benefits of early diagnosis and treatment of sacroiliac joint issues has led to a surge in demand for advanced surgical procedures, further propelling the growth of this market.

How Are Technological Advancements Revolutionizing MIS Sacroiliac Joint Fusion?

Advances in medical technology are at the forefront of the rapid growth in the MIS sacroiliac joint fusion market. Innovations in imaging and navigation systems have significantly enhanced surgical precision, reducing the risk of complications and improving patient outcomes. The development of novel implant materials, such as titanium and bioactive substances, has improved the durability and integration of implants, fostering better recovery and long-term results. Robotic-assisted surgeries and computer-aided planning tools are further streamlining procedures, enabling surgeons to achieve higher accuracy with minimal invasiveness. Moreover, the integration of augmented reality (AR) in surgical planning is transforming how surgeons visualize and approach complex cases. These advancements not only improve clinical efficiency but also increase patient confidence in opting for MIS procedures, thus driving market growth.

What Are the Regional Dynamics Shaping the Market's Trajectory?

The market for MIS sacroiliac joint fusion is expanding unevenly across regions, shaped by diverse healthcare infrastructures, economic conditions, and patient demographics. North America dominates the market, driven by high healthcare spending, well-established reimbursement frameworks, and the availability of advanced medical technologies. Europe is witnessing steady growth, fueled by the rising incidence of sacroiliac joint disorders and a growing preference for minimally invasive procedures. Meanwhile, the Asia-Pacific region represents a burgeoning market with immense potential due to increasing healthcare investments, rising awareness about SI joint dysfunctions, and a rapidly aging population. Governments in emerging economies like India and China are focusing on expanding healthcare access, creating opportunities for market penetration. Additionally, the Middle East and Africa are gradually adopting MIS techniques, spurred by improvements in healthcare infrastructure and increased medical tourism.

What Is Driving Growth in the MIS Sacroiliac Joint Fusion Market?

The growth in the MIS sacroiliac joint fusion market is driven by several factors, including advancements in surgical technology and evolving patient preferences. The rising prevalence of lower back pain and related conditions, particularly among older adults and physically active individuals, has created a robust demand for effective and minimally invasive treatments. Increasing investments in healthcare infrastructure and R&D initiatives have facilitated the development of more efficient and patient-friendly surgical tools and implants. The growing awareness among healthcare professionals about the benefits of early intervention has led to higher adoption rates of these procedures. Furthermore, favorable reimbursement policies in developed regions and the expanding availability of specialized surgical expertise in emerging markets are contributing to market growth. Together, these drivers underscore the strong potential for MIS sacroiliac joint fusion to address an ever-growing healthcare need efficiently and effectively.

SCOPE OF STUDY:

The report analyzes the MIS Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (MIS Sacroiliac Joint Fusion Implants, MIS Sacroiliac Joint Fusion Instruments & Equipment); Approach (Dorsal Approach, Anterior Approach); Indication (Degenerative Sacroiliitis Indication, Trauma Indication, Sacroiliac Joint Dysfunction Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â